UBS Group’s GeoVax Labs Warrants GOVXW Stock Holding History

UBS Group’s Portfolio GOVXW Stock Details GOVXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-539	Closed	-$73	–	9712
2024 Q2	$73	Buy	539 +454	+534%	+$23	﹤0.01%	9200
2024 Q1	$2	Sell	85 -980	-92%	-$38	﹤0.01%	9183
2023 Q4	$32	Buy	+1,065	New	+$102	﹤0.01%	9036
2023 Q2	–	Sell	-151	Closed	-$18	–	9177
2023 Q1	$18	Buy	151 +100	+196%	+$23	﹤0.01%	9432
2022 Q4	$8	Sell	51 -7,436	-99%	-$1.58K	﹤0.01%	10596
2022 Q3	$2K	Buy	7,487 +5,682	+315%	+$2.75K	﹤0.01%	9725
2022 Q2	$1K	Buy	1,805 +1,101	+156%	+$558	﹤0.01%	9872
2022 Q1	$0	Buy	704 +112	+19%	+$87	﹤0.01%	10493
2021 Q4	$1K	Buy	+592	New	+$730	﹤0.01%	9979
2021 Q2	–	Sell	-7,232	Closed	-$9K	–	9528
2021 Q1	$9K	Buy	+7,232	New	+$12.5K	﹤0.01%	8003

Other funds holding GOVXW

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

UBS Group's GOVXW Position: Q3 2024 in Review

UBS Group sold out of GeoVax Labs Warrants (GOVXW) in Q3 2024, closing a stake of 539 shares — an estimated $73 sold.

UBS Group first reported a position in GOVXW in Q1 2021 and held it in 10 quarters. The position peaked at $9K in Q1 2021. 3 funds tracked by Wall St. Rank hold GOVXW as of Q3 2024.

UBS Group reported no remaining GeoVax Labs Warrants position as of Q3 2024 after selling out during the quarter.
UBS Group sold 539 GeoVax Labs Warrants shares in Q3 2024, an estimated $73.
UBS Group first reported a position in GeoVax Labs Warrants in Q1 2021 and held it in 10 quarters.
UBS Group's GeoVax Labs Warrants position peaked at $9K in Q1 2021.
3 funds tracked by Wall St. Rank held GeoVax Labs Warrants as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.